KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

HCA Healthcare (HCA) EBITDA (2016 - 2026)

HCA Healthcare (HCA) has disclosed EBITDA for 17 consecutive years, with -$566.0 million as the latest value for Q1 2026.

  • For Q1 2026, EBITDA rose 62.71% year-over-year to -$566.0 million; the TTM value through Mar 2026 reached -$7.6 billion, down 18.79%, while the annual FY2025 figure was $5.6 billion, 9.62% up from the prior year.
  • EBITDA hit -$566.0 million in Q1 2026 for HCA Healthcare, up from -$4.8 billion in the prior quarter.
  • Across five years, EBITDA topped out at $2.7 billion in Q4 2022 and bottomed at -$4.8 billion in Q4 2025.
  • Average EBITDA over 5 years is $45.3 million, with a median of $1.3 billion recorded in 2022.
  • Year-over-year, EBITDA plummeted 345.15% in 2024 and then soared 62.71% in 2026.
  • HCA Healthcare's EBITDA stood at $2.7 billion in 2022, then fell by 29.88% to $1.9 billion in 2023, then tumbled by 345.15% to -$4.7 billion in 2024, then decreased by 2.12% to -$4.8 billion in 2025, then skyrocketed by 88.27% to -$566.0 million in 2026.
  • According to Business Quant data, EBITDA over the past three periods came in at -$566.0 million, -$4.8 billion, and -$1.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.